Marina(Rybakova)ZemskovaMD
Endocrinology • Rockville, MDDiabetes, Lipid Metabolism
FDA, Medical Officer
Dr. Zemskova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15825 Shady Grove Rd
Suite 140
Rockville, MD 20850Phone+1 301-869-9776Fax+1 301-216-2592
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2006
Capital Health Regional Medical CenterResidency, Internal Medicine, 2000 - 2003
National Medical University KievClass of 1987
Certifications & Licensure
MD State Medical License 2004 - 2025
Publications & Presentations
PubMed
- The Effect of Denosumab on Risk for Emergently Treated Hypocalcemia by Stage of Chronic Kidney Disease : A Target Trial Emulation.Steven T Bird, Kate Gelperin, Elizabeth R Smith, Tae Hyun Jung, Hai Lyu
Annals of Internal Medicine. 2025-01-01 - 18 citationsSevere Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients.Steven T Bird, Elizabeth R Smith, Kate Gelperin, Tae Hyun Jung, Aliza Thompson
JAMA. 2024-02-13 - 1 citationsThe utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine-A cohort study.Hongxiu Luo, Andrew Tobey, Sungyoung Auh, Craig Cochran, Noha Behairy
Frontiers in Pharmacology. 2022-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
